[1]
2022. An Explorative Study of Oral Microemulsion-based Formulation for the Delivery of Cabazitaxel and Piperine. International Journal of Pharmaceutical Sciences and Drug Research. 14, 3 (May 2022), 351–357. DOI:https://doi.org/10.25004/IJPSDR.2022.140307.